Clinical Trial Update: A Study of PEG-EPO Injection (CHO Cells) for Maintenance Therapy of Patients With Renal Anemia . [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on PEG-EPO Injection (CHO Cells) for maintenance therapy in renal anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Anemia

Drugs mentioned

• PEG-EPO Injection (CHO Cells)

Snippet

Sponsor: Angde Biotech Pharmaceutical Co., Ltd. | Conditions: Renal Anemia | Phase 2 | Status: UNKNOWN